​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Most Popular JCP Articles in the Past Week

  1. Treatment-Resistant Schizophrenia: A Brief Overview of Treatment Options

    Justin Faden, DO

  2. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10

    David V. Sheehan, M.D., M.B.A.; Yves Lecrubier, M.D.; K. Harnett Sheehan, Ph.D.; Patricia Amorim M.D., Ph.D.; Juris Janavs, M.D.; Emmanuelle Weiller, M.S.; Thierry Hergueta, M.S.; Roxy Baker; and Geoffrey C. Dunbar, M.D.

  3. Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015–2016

    Gaetano Aloisi, MD; Alessandra Marengoni, MD, PhD; Alessandro Morandi, MD, MPH; Alberto Zucchelli, MD; Antonio Cherubini, MD, PhD; Enrico Mossello, MD, PhD; Mario Bo, MD, PhD; Simona G. Di Santo, PsyD; Andrea Mazzone, MD; Marco Trabucchi, MD, PhD; Stefano Cappa, MD; Filippo L. Fimognari, MD; Raffaele Antonelli Incalzi, MD; Pietro Gareri, MD, PhD; Francesco Perticone, MD; Mauro Campanini, MD; Marco Montorsi, MD; Nicola Latronico, MD; Antonella Zambon, PhD; and Giuseppe Bellelli, MD; on behalf of the Italian Study Group on Delirium (ISGoD)

  4. Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care

    John Lauriello, MD, and Diana O. Perkins, MD

  5. Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

    Eric T. Dobson, MD; Michael H. Bloch, MD, MS; and Jeffrey R. Strawn, MD

  6. Computer-Assisted Cognitive-Behavior Therapy for Depression: A Systematic Review and Meta-Analysis

    Jesse H. Wright, MD, PhD; Jesse J. Owen, PhD; Derek Richards, PhD; Tracy D. Eells, PhD; Thomas Richardson, PhD; Gregory K. Brown,PhD; Marna Barrett,PhD; Mary Ann Rasku, MD; Geneva Polser, MEd; and Michael E. Thase, MD

  7. Advanced Topics in Major Depressive Disorder: Practical Strategies to Improve Remission

    Rakesh Jain, MD

  8. Comparative Risk of Seizure With Use of First- and Second-Generation Antipsychotics in Patients With Schizophrenia and Mood Disorders

    Chi-Shin Wu, MD, PhD; Sheng-Chang Wang, MD, MSc; I-Jin Yeh, MD; and Shi-Kai Liu, MD

  9. Diagnosing and Treating Patients With Mixed Features

    Rakesh Jain, MD, MPH; Vladimir Maletic, MD, MS; and Roger S. McIntyre, MD, FRCPC

  10. Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer’s Disease: A Meta-Analysis

    Myuri Ruthirakuhan, MSc; Krista L. Lanctôt, PhD; Danielle Vieira, BSc; and Nathan Herrmann, MD